192 related articles for article (PubMed ID: 27490558)
21. Polymorphisms of NAT2, CYP2E1, GST, and HLA related to drug-induced liver injury in indonesian tuberculosis patients.
Perwitasari DA; Darmawan E; Mulyani UA; Vlies PV; Alffenaar JC; Atthobar J; Wilffert B
Int J Mycobacteriol; 2018; 7(4):380-386. PubMed ID: 30531039
[TBL] [Abstract][Full Text] [Related]
22. Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs.
Chamorro JG; Castagnino JP; Musella RM; Nogueras M; Aranda FM; Frías A; Visca M; Aidar O; Perés S; de Larrañaga GF
J Gastroenterol Hepatol; 2013 Feb; 28(2):323-8. PubMed ID: 23190413
[TBL] [Abstract][Full Text] [Related]
23. Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis.
Huang YS; Chern HD; Su WJ; Wu JC; Chang SC; Chiang CH; Chang FY; Lee SD
Hepatology; 2003 Apr; 37(4):924-30. PubMed ID: 12668988
[TBL] [Abstract][Full Text] [Related]
24. The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.
Xiang Y; Ma L; Wu W; Liu W; Li Y; Zhu X; Wang Q; Ma J; Cao M; Wang Q; Yao X; Yang L; Wubuli A; Merle C; Milligan P; Mao Y; Gu J; Xin X
PLoS One; 2014; 9(1):e85905. PubMed ID: 24465778
[TBL] [Abstract][Full Text] [Related]
25. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
[TBL] [Abstract][Full Text] [Related]
26. [Association of P450-2E1 and GSTM1 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity].
Wang T; Wang W; Wang ZY; Pan YY; Su QQ; He LX
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Aug; 32(8):585-7. PubMed ID: 19958676
[TBL] [Abstract][Full Text] [Related]
27. NAT2 and CYP2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis.
Lee SW; Chung LS; Huang HH; Chuang TY; Liou YH; Wu LS
Int J Tuberc Lung Dis; 2010 May; 14(5):622-6. PubMed ID: 20392357
[TBL] [Abstract][Full Text] [Related]
28. The association between CYP2E1 polymorphisms and hepatotoxicity due to anti-tuberculosis drugs: a meta-analysis.
Sheng YJ; Wu G; He HY; Chen W; Zou YS; Li Q; Zhong L; Huang YM; Deng CL
Infect Genet Evol; 2014 Jun; 24():34-40. PubMed ID: 24607341
[TBL] [Abstract][Full Text] [Related]
29. Global DNA hypomethylation of Alu and LINE-1 transposable elements as an epigenetic biomarker of anti-tuberculosis drug-induced liver injury.
Udomsinprasert W; Sakuntasri W; Jittikoon J; Chaikledkaew U; Honsawek S; Chantratita W; Wattanapokayakit S; Mahasirimongkol S
Emerg Microbes Infect; 2021 Dec; 10(1):1862-1872. PubMed ID: 34467830
[TBL] [Abstract][Full Text] [Related]
30. The association between cytochrome P450 polymorphisms and anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis.
Liu X; Ren S; Zhang J; Xu D; Jiang F; Jiang P; Feng J; Deng F
Ann Palliat Med; 2021 Jun; 10(6):6518-6534. PubMed ID: 34154362
[TBL] [Abstract][Full Text] [Related]
31. Association of POR and PPARα polymorphisms with risk of anti-tuberculosis drug-induced liver injury in Western Chinese Han population.
Zhang C; Jiao L; Bai H; Zhao Z; Hu X; Wang M; Wu T; Peng W; Liu T; Song J; Zhou J; Li M; Lyv M; Zhang J; Chen H; Chen J; Ying B
Infect Genet Evol; 2020 Apr; 79():104147. PubMed ID: 31857256
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms of cytochrome P450 and glutathione S-transferase associated with antituberculosis drug-induced hepatotoxicity in Chinese tuberculosis patients.
Wang T; Yu HT; Wang W; Pan YY; He LX; Wang ZY
J Int Med Res; 2010; 38(3):977-86. PubMed ID: 20819434
[TBL] [Abstract][Full Text] [Related]
33. Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia.
Marsh JC; Chowdry J; Parry-Jones N; Ellis SW; Muir KR; Gordon-Smith EC; Tucker GT
Br J Haematol; 1999 Feb; 104(2):266-70. PubMed ID: 10050706
[TBL] [Abstract][Full Text] [Related]
34. Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control study.
Yang M; Zhang H; Tao B; Pan H; Lu L; Yi H; Tang S
J Clin Pharm Ther; 2019 Aug; 44(4):534-542. PubMed ID: 30776144
[TBL] [Abstract][Full Text] [Related]
35.
Jaramillo-Valverde L; Levano KS; Tarazona DD; Vasquez-Dominguez A; Toledo-Nauto A; Capristano S; Sanchez C; Tarazona-Santos E; Ugarte-Gil C; Guio H
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232322
[TBL] [Abstract][Full Text] [Related]
36. Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients.
Ben Fredj N; Gam R; Kerkni E; Chaabane A; Chadly Z; Boughattas N; Aouam K
Pharmacogenomics J; 2017 Jul; 17(4):372-377. PubMed ID: 27089936
[TBL] [Abstract][Full Text] [Related]
37. N-acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians.
Rana SV; Sharma SK; Ola RP; Kamboj JK; Malik A; Morya RK; Sinha SK
J Clin Pharm Ther; 2014 Feb; 39(1):91-6. PubMed ID: 24188272
[TBL] [Abstract][Full Text] [Related]
38. The role of NAT2 polymorphism and methylation in anti-tuberculosis drug-induced liver injury in Mongolian tuberculosis patients.
Zhang D; Hao J; Hou R; Yu Y; Hu B; Wei L
J Clin Pharm Ther; 2020 Jun; 45(3):561-569. PubMed ID: 32364660
[TBL] [Abstract][Full Text] [Related]
39. Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis.
Bose PD; Sarma MP; Medhi S; Das BC; Husain SA; Kar P
J Gastroenterol Hepatol; 2011 Feb; 26(2):312-8. PubMed ID: 21261721
[TBL] [Abstract][Full Text] [Related]
40. Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study.
Chen S; Pan H; Chen Y; Lu L; He X; Chen H; Chen R; Zhan S; Tang S
Sci Rep; 2019 Oct; 9(1):14311. PubMed ID: 31586142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]